Halozyme proposes follow-on

Halozyme Therapeutics Inc. (NASDAQ:HALO) proposed late Wednesday to sell 8.3 million shares in a follow-on underwritten by Barclays Capital. If sold at Wednesday's close of $7.99, the company would raise $66.3 million. Halozyme was up $0.21 on the day. ...